Page last updated: 2024-09-02

pyronaridine and Lung Neoplasms

pyronaridine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, M; Coghi, PS; Fan, XX; He, QD; Jiang, ZB; Leung, EL; Tong, ZY; Wang, J; Xie, YJ; Xu, C; Yao, XJ; Yi, ZL; Zhao, YD; Zhong, ZH	1

Other Studies

1 other study(ies) available for pyronaridine and Lung Neoplasms

Article	Year
Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor. Chemical biology & drug design, 2022, Volume: 99, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Humans; Lung Neoplasms; Naphthyridines; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Up-Regulation	2022

Article

Year

Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor.

Chemical biology & drug design, 2022, Volume: 99, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Humans; Lung Neoplasms; Naphthyridines; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Up-Regulation

2022